Horizons Marijuana Life Sciences Index ETF

Latest Horizons Marijuana Life Sciences Index ETF News and Updates

  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Do CGC, ACB, TLRY, and APHA Look Cheap?

    With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Markets Rebound but Cannabis Stock Performance Is Mixed

    Markets rebounded today after the recent sell-off fueled by US-China trade tensions.

    By Adam Jones
  • uploads///cannabis _
    Miscellaneous

    Canaccord Genuity Raises Price Target for Canopy Growth

    On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///can_
    Cannabis

    Cannabis Legalization: Four Governors Met in New York

    The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

    By Rajiv Nanjapla
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///c
    Miscellaneous

    Canopy Growth Receives Target Price Upgrades

    Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.

    By Adam Jones
  • uploads///green _
    Company & Industry Overviews

    Tilray Invests in ROSE LifeScience

    On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.

    By Adam Jones
  • uploads///hexo
    Cannabis

    HEXO: Analysts’ Target Price and Ratings

    CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///Canopy_
    Cannabis

    Can Canopy Beat Q2 Estimates and Boost the Sector?

    This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    Cannabis and Vaping Concerns: Will the Dream Go Up in Smoke?

    Cannabis legalization is a vital topic in the US. Meanwhile, vaping related deaths continue to rise. Will vaping concerns kill the US cannabis dream?

    By Sushree Mohanty
  • uploads///mariju
    Cannabis

    Marijuana Vape Products Expected in Alberta Stores

    AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

    By Rajiv Nanjapla
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What to Expect from Its Q4 Results

    Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.

    By Sushree Mohanty
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///marijuana hashish leaf flowerpot
    Cannabis

    Big News: Cannabis Edibles in Alberta Stores

    Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

    By Rajiv Nanjapla
  • uploads///california marijuana future
    Cannabis

    Marijuana Industry: Opportunities in California amid COVID-19

    Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Canada’s Cannabis Act C-45 Makes Progress in the Senate

    On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.

    By Adam Jones
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    Price Target Update for Canopy Growth in January

    Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.

    By Adam Jones
  • uploads///Chart
    Company & Industry Overviews

    MedMen’s Must-Know Revenue Drivers

    MedMen’s (MMNFF) reported revenues are generated from direct sales through its retail stores. The company has reported no material revenues from cultivation or production wholesale operations.

    By Mike Benson
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • Cannabis

    Cannabis 2.0 Legalization: Canada Is Ready

    Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Beverages: Why Canadians Can’t Wait

    Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.

    By Sushree Mohanty
  • uploads///cannabis edibles
    Cannabis

    No Cannabis Edibles in Three Provinces for Christmas

    After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.

    By Sushree Mohanty
  • uploads///cannabsis
    Cannabis

    Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market

    Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

    By Sushree Mohanty
  • uploads///Household Consumption Expenditure on Cannabis
    Company & Industry Overviews

    Why Cannabis Stocks Are on the Rise

    The reason cannabis stocks are rising could be because October 17 is approaching.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Canopy Growth to Get Extract Supply from MediPharm Labs

    On November 29, Canopy Growth (WEED) entered an 18-month supply agreement with MediPharm Labs.

    By Adam Jones
  • uploads/// Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    How Aurora Cannabis’s Valuations Compare to Its Peers’

    On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///marijuana hashish leaf flowerpot
    Earnings Report

    Canopy Growth Reported Its Q1 2019 Results on August 14

    Canopy Growth reported its earnings for the first quarter of 2019 on August 14. The company is one of the largest cannabis producers by capacity.

    By Adam Jones
  • uploads///IIPR
    Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///CGC
    Cannabis

    CGC: How the Future Looks Under Its New CEO

    On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

    By Margaret Patrick
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Is This the Right Time to Invest?

    Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?

    By Sushree Mohanty
  • uploads///Inventory Biological Assets
    Earnings Report

    How Canopy Growth Is Preparing for Legalized Cannabis

    During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.

    By Adam Jones
  • uploads///Aphria
    Cannabis

    Aphria: Analysts’ Target Price and Ratings

    While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Are Its Q4 Results Good or Bad News?

    Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?

    By Sushree Mohanty
  • uploads///Tlry
    Company & Industry Overviews

    Tilray Makes a Bold Prediction on Cannabis Legalization in the US

    Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.

    By Adam Jones
  • uploads///marijuanaI
    Cannabis

    New Year Will Bring Legal Marijuana to Illinois Residents

    Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Raymond James Foresees a Cannabis Rebound in 2020

    Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]

    By Sushree Mohanty
  • uploads///seedling _
    Company & Industry Overviews

    The Market Is Sinking and Taking the Cannabis Sector Along

    This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Why Tilray Cannabis Stock Popped Today

    On September 18, cannabis stock Tilray (TLRY) popped about 27% to an all-time high of $153.8 in the mid-day session.

    By Adam Jones
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What’s the Word on the Street?

    Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///ACB_
    Cannabis

    Aurora Cannabis Releases Update on Cannabis 2.0

    Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    What’s the Market Potential for CBD?

    The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

    By Margaret Patrick
  • uploads///marijuana _
    Company & Industry Overviews

    Key Developments in the Cannabis Sector Last Week

    The week ending February 16 wasn’t so positive for marijuana stocks even though the broader market indexes ended in the positive territory.

    By Adam Jones
  • uploads///cannabis
    Company & Industry Overviews

    Cannabis Stocks: Will Tough Times End Soon?

    Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

    By Sushree Mohanty
  • uploads///mexico
    Cannabis

    Will Mexico Legalize Cannabis by the End of the Month?

    With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

    By Rajiv Nanjapla
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.